Minocycline-induced cutaneous polyarteritis nodosa

Journal of Clinical Rheumatology

Volumn 13, Issue 3, 2007, Pages 146-149

  Tehrani, Rodney ^a   Nash Goelitz, Alyssa ^b   Adams, Elaine ^a   Dahiya, Madhu ^c   Eilers, David ^a,d  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b Jr Hospital of Cook County   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d HINES VA HOSPITAL   (United States)

Author keywords

Cutaneous polyarteritis nodosa; Minocycline; Systemic lupus erythematosus

Indexed keywords

ANTINUCLEAR ANTIBODY; ISOTRETINOIN; MINOCYCLINE;

ACNE VULGARIS; ADULT; AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY TITER; ARTHRALGIA; ARTICLE; CASE REPORT; DRUG SAFETY; DRUG WITHDRAWAL; EOSINOPHIL; FEMALE; FLU LIKE SYNDROME; HISTIOCYTE; HUMAN; HYPERPIGMENTATION; LYMPHOCYTIC INFILTRATION; MALAISE; POLYARTERITIS NODOSA; PRIORITY JOURNAL; SKIN BIOPSY; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT WITHDRAWAL;

ACNE VULGARIS; ADOLESCENT; ANTI-BACTERIAL AGENTS; ANTIBODIES, ANTINUCLEAR; FEMALE; HUMANS; MINOCYCLINE; POLYARTERITIS NODOSA;

EID: 34249995987     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/RHU.0b013e3180690693     Document Type: Article

References (19)

1. Schrodt BJ, Callen JP. Polyarteritis nodosa attributable to minocycline treatment for acne vulgaris. Pediatrics. 1999;103:503-505.
2. Schaffer JV, Davidson DM, McNiff JM, et al. Perinuclear antineutrophilic cytoplasmic antibody-positive cutaneous polyarteritis nodosa associated with minocycline therapy for acne vulgaris. J Am Acad Derm. 2001;44:198-206.
3. Gough A, Chapman S, Wagstaff K, et al. Minocycline induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome. Br Med J. 1996;312:169-172.
4. Crosson J, Stillman MT. Minocycline-related lupus erythematosus with associated liver disease. J Am Acad Derm. 1997;36:867-868.
5. Matsuura T, Shimizu Y, Fujimoto H, et al. Minocycline-related lupus. Lancet. 1992;340:1553.
6. Byrne PAC, Williams BD, Pritchard MH. Minocycline-related lupus. Br J Rheum. 1994;33:674-676.
7. Gordon PM, White MI, Herriot R, et al. Minocycline-associated lupus erythematosus. Br J Derm. 1995;132:120-121.
8. Elkayam O, Levartovsky D, Brautbar C, et al. Clinical and immunological study of 7 patients with minocycline-induced autoimmune phenomena. Am J Med. 1998;105:484-487.
9. Culver B, Itkin A, Pischel K. Case report and review of minocycline-induced cutaneous polyarteritis nodosa. Arthritis Rheum. 2005;53:468-470.
10. Elkayam O, Yaron M, Caspi D. Minocycline induced arthritis associated with fever, livedo reticularis, and p-ANCA. Ann Rheum Dis. 1996;55:769-771.
11. Hess E. Drug-related lupus. New Engl J Med. 1988;318:1460-1462.
12. Angulo JM, Sigal LH, Espinoza LR. Coexistent minocycline-induced systemic lupus erythematosus and autoimmune hepatitis. Semin Arthritis Rheum. 1998;28:187-192.
13. Hughes GRV. Recent developments in drug-associated systemic lupus erythematosus. Adverse Drug React Bull. 1987;123:460-463.
14. Yamamoto K, Kawanishi S. Free radical production and site-specific DNA damage induced by hydralazine in the presence of metal ions of peroxidase/hydrogen peroxide. Biochem Pharmacol. 1991;41:905-913.
15. Hofstra AH, Li-Muller SMA, Uetrecht JP. Metabolism of isoniazid by activated leukocytes: possible role in drug induced lupus. Drug Metab Dispos. 1992;20:205-210.
16. Dunphy J, Oliver M, Rands AL, et al. Antineutrophil cytoplasmic antibodies and HLA class II alleles in minocycline-induced lupus-like syndrome. Br J Derm. 2000;142:461-467.
17. Lanctot KL, Naranjo CA. Comparison of the Bayesian approach and a simple algorithm for the assessment of adverse drug events. Clin Pharmacol Ther. 1995;58:692-698.
18. Saka H, Komatsu S, Matsuo S, et al. Two cases of minocyclin-induced vasculitis. Arerugi. 2002;51:1153-1158.
19. Pelletier F, Puzenat E, Blanc D, et al. Minocycline-induced cutaneous polyarteritis nodosa with antineutrophil cytoplasmic antibodies. Eur J Dermatol. 2003;13:396-398.